Cuts aimed at the National Institutes of Health in a Feb. 7 announcement from President Donald Trump could have stark impacts for the life sciences real estate industry, which is already struggling under the weight of supply overages and soft demand.
The proposed cuts were paused by the order of a federal judge and subject to a Feb. 21 hearing, but would potentially have rippling impacts, including interrupting underwriting assumptions for lab real estate projects that involve universities and slowing the pace of innovation that remains the lifeblood of the biotech industry.
“It’s going to touch real estate,” said Project Management Advisors Senior Project Manager…
Source: NIH Cuts To Stifle Demand Driver For Life Sciences Space